Bessemer Group’s Lifecore Biomedical LFCR Stock Holding History

Bessemer Group’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,000	Closed	-$36K	–	2042
2022 Q3	$36K	Hold	4,000	–	–	﹤0.01%	1241
2022 Q2	$40K	Hold	4,000	–	–	﹤0.01%	1146
2022 Q1	$46K	Hold	4,000	–	–	﹤0.01%	1097
2021 Q4	$44K	Hold	4,000	–	–	﹤0.01%	1155
2021 Q3	$37K	Hold	4,000	–	–	﹤0.01%	1117
2021 Q2	$45K	Hold	4,000	–	–	﹤0.01%	1085
2021 Q1	$42K	Hold	4,000	–	–	﹤0.01%	1043
2020 Q4	$43K	Hold	4,000	–	–	﹤0.01%	1018
2020 Q3	$39K	Sell	4,000 -89,900	-96%	-$856K	﹤0.01%	957
2020 Q2	$747K	Hold	93,900	–	–	﹤0.01%	880
2020 Q1	$816K	Hold	93,900	–	–	﹤0.01%	655
2019 Q4	$1.06M	Sell	93,900 -400	-0.4%	-$4.26K	﹤0.01%	727
2019 Q3	$1.02M	Buy	94,300 +15,500	+20%	+$169K	﹤0.01%	692
2019 Q2	$738K	Sell	78,800 -17,700	-18%	-$179K	﹤0.01%	776
2019 Q1	$1.19M	Buy	96,500 +38,400	+66%	+$469K	﹤0.01%	593
2018 Q4	$688K	Buy	58,100 +18,500	+47%	+$254K	﹤0.01%	669
2018 Q3	$570K	Buy	39,600 +16,700	+73%	+$231K	﹤0.01%	731
2018 Q2	$341K	Buy	22,900 +5,400	+31%	+$75K	﹤0.01%	871
2018 Q1	$228K	Hold	17,500	–	–	﹤0.01%	988
2017 Q4	$221K	Hold	17,500	–	–	﹤0.01%	1002
2017 Q3	$227K	Hold	17,500	–	–	﹤0.01%	1035
2017 Q2	$260K	Buy	+17,500	New	+$244K	﹤0.01%	1007
2013 Q4	–	Sell	-44,226	Closed	-$540K	–	1369
2013 Q3	$540K	Sell	44,226 -86,064	-66%	-$1.2M	﹤0.01%	528
2013 Q2	$1.72M	Buy	+130,290	New	+$1.8M	0.02%	315

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Bessemer Group's LFCR Position: Q4 2022 in Review

Bessemer Group sold out of Lifecore Biomedical (LFCR) in Q4 2022, closing a stake of 4,000 shares — an estimated $36K sold.

Bessemer Group first reported a position in LFCR in Q2 2013 and held it in 24 quarters. The position peaked at $1.72M in Q2 2013. 93 funds tracked by Wall St. Rank hold LFCR as of Q4 2022.

Bessemer Group reported no remaining Lifecore Biomedical position as of Q4 2022 after selling out during the quarter.
Bessemer Group sold 4,000 Lifecore Biomedical shares in Q4 2022, an estimated $36K.
Bessemer Group first reported a position in Lifecore Biomedical in Q2 2013 and held it in 24 quarters.
Bessemer Group's Lifecore Biomedical position peaked at $1.72M in Q2 2013.
93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2022.

Based on Bessemer Group's 13F filing for Q4 2022, filed 13 Feb 2023.